News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
finance.yahoo.com Earnings
On August 5, Symbotic Inc. (NASDAQ:SYM) reported a quarter that looked almost too good, with revenue up 22% and profit swinging from a loss to tens of millions in the black. Yet a chunk of Wall Street is still betting against the stock. That gap between the fundamentals and the skepticism is the story here.What's Really Behind Symbotic's …
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Symbotic Inc. reported a swing to profit with US$11.67 million in net income and US$720.84 million in revenue for Q3 2026, alongside higher Q4 revenue guidance of US$760 million to US$780 million. Despite these positive financial results and improved operational efficiency, the stock dropped …
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Symbotic Inc. (NASDAQ: SYM) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss potential corporate governance reforms, return of funds to the …
Microbot Medical Inc. announced a 100% quarter-over-quarter revenue and customer growth for Q2 2026, driven by the successful Full Market Release of its LIBERTY System. The company expanded its market presence in the U.S., secured a federal healthcare agreement, and achieved international marketing clearance …
Microbot Medical Inc. reported its Q2 2026 results, announcing its first commercial revenue of $241,000, a significant increase from zero in the previous year. Despite this, the company posted a net loss of $5.63 million, worsening from a $3.5 million loss in the prior-year …
Microbot Medical (NASDAQ: MBOT) reported Q2 EPS of $(0.08), meeting analyst estimates and showing a 20% improvement year-over-year. However, the company's sales of $241,000 significantly missed the estimated $340,000 by 29.12%, raising concerns about its top-line growth despite improved per-share losses. This discrepancy suggests …
Microbot Medical (NASDAQ:MBOT) announced its earnings results, reporting a quarterly loss of $0.08 per share, which met analyst expectations, but revenue of $0.24 million fell short of the $0.33 million consensus. Following the announcement, shares declined 13.4% to $1.68, nearing the company's one-year low. …
Microbot Medical has partnered with Lovell Government Services to expand its reach into federal healthcare systems, gaining access to over 2,000 facilities for its LIBERTY endovascular robotic system. Concurrently, Microbot signed an agreement with Sanmina to establish a second manufacturing site, anticipating increased demand. …
Microbot Medical Inc. (MBOT) reported a Q2 loss of $0.08 per share, in line with the Zacks Consensus Estimate, but missed revenue expectations with $0.24 million against an anticipated $0.31 million. Despite underperforming the market year-to-date, the company holds a Zacks Rank #2 (Buy), …
Microbot Medical (NASDAQ: MBOT) has reported its first commercial revenue from the LIBERTY® Endovascular Robotic System, totaling $241,000 in Q2 2026 and $346,000 for the first half of 2026. Despite these initial sales, the company incurred a net loss of $5.6 million for the …
Microbot Medical (NASDAQ: MBOT) reported over 100% revenue and customer growth in Q2 2026, driven by the successful Full Market Release of its LIBERTY endovascular robotic system. The company expanded its U.S. sales territories, partnered for access to federal healthcare facilities, and received marketing …
This Yahoo Finance page provides a snapshot of Embotelladora Andina S.A. (ANDINA-A.SN), including its current stock price, recent performance, and dividend announcement. The company's stock closed at 3,683.70 CLP, down 0.33%, and has declared a cash dividend of CLP 51.00 with an ex-date of …
Microbot Medical has filed its 10-Q report, indicating significant revenue and customer growth during the second quarter of 2026. This suggests positive financial performance for the company in the recent period.
Microbot Medical Inc. has increased the annual base salary of its CFO, Rachel Vaknin, to NIS 864,000 (equivalent to $288,000) effective August 1, 2026. This adjustment comes as the company, with a $126.6 million market cap, navigates profitability challenges despite recent significant revenue growth …
This article provides a comprehensive overview of Symbotic Inc. Class A (SYM) stock performance, fundamentals, valuation, and analyst recommendations for Indian investors. It details the company's live share price, historical returns, key financial indicators, and compares it to industry peers. The article also includes …
This article announces that Microbot Medical Inc. filed a Form 8K on August 7th. The brief piece includes a stock symbol (MBOT) and its current price performance (+5.00%). The main content simply reiterates the filing and provides a link to view comments.
Walmart Inc. has reported an updated beneficial ownership of 76,350,823 shares of Symbotic Inc. Class A common stock on an as-converted basis, which represents 39.9% of Class A common stock. This percentage is based on 129,873,381 Class A shares outstanding as of August 3, …
Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup negative 34.3%Symbotic (SYM) stock experienced a 15% drop despite reporting strong Q3 2026 earnings, including a doubling of adjusted EBITDA and a shift to profitability. While the company is making significant progress in its profit engine and software/services mix, concerns over customer concentration and delays …
Symbotic Inc. director Charles Kane reported a pre-arranged Rule 10b5-1 transaction on August 3, 2026. He redeemed 2,000 Symbotic Holdings Units and corresponding Class V-1 voting shares for 2,000 Class A shares, then sold those shares at $43.21 each, totaling approximately $86,420. After the …
Search by ticker symbol or company name and select a result to open its chart.